Search results
Results From The WOW.Com Content Network
Heparin, also known as unfractionated heparin (UFH), is a medication and naturally occurring glycosaminoglycan. [3] [4] Heparin is a blood anticoagulant that increases the activity of antithrombin. [5] It is used in the treatment of heart attacks and unstable angina. [3] It can be given intravenously or by injection under the skin. [3]
heparin: 0.05-0.1 [1] insulin: 0.05-0.1 [1] warfarin: 0.1-0.2 [1] sulfamethoxazole: 0.1-0.2 [1] glibenclamide: ... [1] chloroquine: 200 [2] References & footnotes
Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. [1] They are used in the prevention of blood clots and, in the treatment of venous thromboembolism ( deep vein thrombosis and pulmonary embolism ), and the treatment of myocardial infarction .
[1] [2] [3] Subgroup B01 is part of the anatomical group B Blood and blood forming organs. [4] Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QB01. [5] National issues of the ATC classification may include additional codes not present in this list, which follows the ...
I (User:MattKingston) am in the process of creating a list of drugs and their various names. The list will be alphabetical and will use the following format (subject to change if better suggestions are put forward). All items in the list will follow the general format: Name of drug (who calls it that) [country]. Redirects to name of drug.
The medication is contraindicated in patients with a history of heparin-induced thrombocytopenia with or without disseminated intravascular coagulation; acute bleeding or risk of bleeding; injury or surgery of the central nervous system, eyes or ears; severe liver or pancreas impairment; and acute or subacute bacterial endocarditis. [2]
between 2008 and 2012, better performance than 1% of all directors The Linda B. Bammann Stock Index From December 2008 to December 2012, if you bought shares in companies when Linda B. Bammann joined the board, and sold them when she left, you would have a -62.3 percent return on your investment, compared to a 61.1 percent return from the S&P 500.
Platelet factor 4 can cause heparin-induced thrombocytopenia. The package insert states that prothrombin complex concentrate is contraindicated in patients with disseminated intravascular coagulation, a pathological activation of coagulation, [24] because giving clotting factors would only further fuel this process. However, if the PCC is given ...